Clinical Trials Browser

Phase 1/2 × Neoplasms × Cell- and Tissue-Based Therapy × Clear all

NCT06096038 2026-02-20

Autologous CAR-T Cells Targeting CSPG4 in Relapsed/Refractory HNSCC

Phase 1/2 Recruiting

Head and Neck Neoplasms, Neoplasms, Recurrence